Ajinomoto Builds Gene Therapy CDMO Capabilities Through $554m Forge Acquisition

 
• By Lisa Takagi
  
Forge will join Ajinomoto's CDMO business as wholly-owned subsidiary.
Forge will join Ajinomoto's CDMO business as wholly-owned subsidiary • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip